Unknown

Dataset Information

0

A De Novo heterozygous frameshift mutation identified in BCL11B causes neurodevelopmental disorder by whole exome sequencing.

ABSTRACT: BACKGROUND:Next-generation sequencing has been invaluable to delineate the genetic etiology of neurodevelopmental disorders (NDDs) in recent years. BCL11B, encoding Cys2 His2 zinc finger transcription factor, is essential for the development of immune and neural systems. METHODS:Herein, we describe a Chinese girl presenting craniofacial abnormalities, developmental delay and intellectual disability with speech impairment. Exomes of genes were enriched with the Agilent SureSelect QXT ALL Human Exon V6 kit and sequenced on Illumina Hiseq 2500 platform. RESULTS:After variants filtering and annotation, we identified a de novo heterozygous 11bp frameshift mutation NM_138576.4: c.2190_2200delGGACGCACGAC (p.Thr730Thrfs*151) in exon 4 of BCL11B, which is expected to escape nonsense-mediated mRNA decay and probably result in a truncated protein with lack of the C-terminal DNA-binding zinc-finger domains. CONCLUSION:This is the first report of NDD caused by a BCL11B variant in a Chinese population. The mutation identified in this report broadens the knowledge of mutation spectrum of BCL11B and might help in genetic counseling and reducing reproductive risk.

SUBMITTER: Qiao F 

PROVIDER: S-EPMC6732278 | biostudies-literature | 2019 Sep

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

A De Novo heterozygous frameshift mutation identified in BCL11B causes neurodevelopmental disorder by whole exome sequencing.

Qiao Fengchang F   Wang Chen C   Luo Chunyu C   Wang Yan Y   Shao Binbin B   Tan Jianxin J   Hu Ping P   Xu Zhengfeng Z  

Molecular genetics & genomic medicine 20190725 9

<h4>Background</h4>Next-generation sequencing has been invaluable to delineate the genetic etiology of neurodevelopmental disorders (NDDs) in recent years. BCL11B, encoding Cys<sub>2</sub> His<sub>2</sub> zinc finger transcription factor, is essential for the development of immune and neural systems.<h4>Methods</h4>Herein, we describe a Chinese girl presenting craniofacial abnormalities, developmental delay and intellectual disability with speech impairment. Exomes of genes were enriched with th  ...[more]

Similar Datasets

Unknown A Novel De Novo Frameshift Mutation in <i>KAT6A</i> Identified by Whole Exome Sequencing.
| S-EPMC6375718 | biostudies-literature
Unknown Phenotypes of a female patient with novel de novo frameshift ARX variant identified by whole-exome sequencing: a case report.
| S-EPMC9949785 | biostudies-literature
Unknown Whole-exome sequencing identified five novel de novo variants in patients with unexplained intellectual disability.
| S-EPMC9459325 | biostudies-literature
Unknown Whole exome sequencing identifies de novo heterozygous CAV1 mutations associated with a novel neonatal onset lipodystrophy syndrome.
| S-EPMC5086082 | biostudies-literature
Unknown <i>De novo</i> Mutations From Whole Exome Sequencing in Neurodevelopmental and Psychiatric Disorders: From Discovery to Application.
| S-EPMC6456656 | biostudies-literature
Unknown Three de novo variants in KMT2A (MLL) identified by whole exome sequencing in patients with Wiedemann-Steiner syndrome.
| S-EPMC8580087 | biostudies-literature
Unknown De novo mutations in COL4A5 identified by whole exome sequencing in 2 girls with Alport syndrome in Korea.
| S-EPMC6528060 | biostudies-literature
Unknown De Novo Heterozygous POLR2A Variants Cause a Neurodevelopmental Syndrome with Profound Infantile-Onset Hypotonia.
| S-EPMC6699192 | biostudies-literature
Unknown A de novo frameshift pathogenic variant in TBR1 identified in autism without intellectual disability.
| S-EPMC7501624 | biostudies-literature
Unknown Whole-Exome Sequencing Identifies Damaging de novo Variants in Anencephalic Cases.
| S-EPMC6896715 | biostudies-literature